Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (Q63229239)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa
clinical trial

    Statements

    EASE (English)
    0 references
    Double Blind, Randomised, Vehicle Controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    29 March 2017
    0 references
    December 2019
    0 references
    250
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit